Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $29.49 USD
Change Today -0.67 / -2.22%
Volume 148.6K
EBS On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Louis W. Sullivan M.D.

Director, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 175 board members in 13 different organizations across 20 different industries.

See Board Relationships
80$461,600

Background*

Dr. Louis W. Sullivan, M.D. is the Founder and Chairman of the Board of Medical Education at South African Blacks, Inc. Dr. Sullivan serves as Founding Dean of the Morehouse School of Medicine in Atlanta, where he works to develop a center to focus on the AIDS epidemic in Africa. He served as the President Emeritus of the Morehouse School Of Medicine Inc. since June 2002. He served as Secretary of Health and Human Services in the cabinet of President George H.W. Bush ...

Read Full Background

Corporate Headquarters*

400 Professional Drive
Gaithersburg, Maryland 20879

United States

Phone: 240-631-3200
Fax: --

Board Members Memberships*

Former Director
Director
Director
Former Director
President Emeritus and Trustee
Vice Chairman of the Board
Director
Trustee
1993-2006
Former Director
1993-N/A
Former Director, Member of Corporate Governance Committee and Member of People Resources Committee
1993-N/A
Former Director and Member of Audit Committee
1993-N/A
Former Director
1995-2004
Former Director
1996-N/A
Chairman, Chairman of Compensation Committee, Member of Audit & Finance Committee and Member of Nominating & Corporate Governance Committee
2002-Present
Director, Member of the Scientific Advisory Board, Member of Nominating & Governance Committee, Member of Compensation Committee and Member of Scientific Committee
2003-2007
Former Independent Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2003-Present
Director, Chairman of Medical Advisory Board, Member of Nominating & Governance Committee and Member of Strategic Advisory Committee
2006-Present
Director, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education*

BS 1954
Morehouse College
MD 1958
Boston University School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$80,000
Total Calculated Compensation$461,600
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $29.49 USD -0.67

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.7M
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
$696.1K
Mark C. Rohr Chairman of the Board, Chief Executive Officer and President
Celanese Corporation
$1.1M
Shigenobu Maekawa President and Representative Director
Nippon Shinyaku Co. Ltd.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.